Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
PLoS Genet ; 18(11): e1010477, 2022 11.
Article in English | MEDLINE | ID: mdl-36350884

ABSTRACT

Myelin is essential for rapid nerve impulse propagation and axon protection. Accordingly, defects in myelination or myelin maintenance lead to secondary axonal damage and subsequent degeneration. Studies utilizing genetic (CNPase-, MAG-, and PLP-null mice) and naturally occurring neuropathy models suggest that myelinating glia also support axons independently from myelin. Myelin protein zero (MPZ or P0), which is expressed only by Schwann cells, is critical for myelin formation and maintenance in the peripheral nervous system. Many mutations in MPZ are associated with demyelinating neuropathies (Charcot-Marie-Tooth disease type 1B [CMT1B]). Surprisingly, the substitution of threonine by methionine at position 124 of P0 (P0T124M) causes axonal neuropathy (CMT2J) with little to no myelin damage. This disease provides an excellent paradigm to understand how myelinating glia support axons independently from myelin. To study this, we generated targeted knock-in MpzT124M mutant mice, a genetically authentic model of T124M-CMT2J neuropathy. Similar to patients, these mice develop axonopathy between 2 and 12 months of age, characterized by impaired motor performance, normal nerve conduction velocities but reduced compound motor action potential amplitudes, and axonal damage with only minor compact myelin modifications. Mechanistically, we detected metabolic changes that could lead to axonal degeneration, and prominent alterations in non-compact myelin domains such as paranodes, Schmidt-Lanterman incisures, and gap junctions, implicated in Schwann cell-axon communication and axonal metabolic support. Finally, we document perturbed mitochondrial size and distribution along MpzT124M axons suggesting altered axonal transport. Our data suggest that Schwann cells in P0T124M mutant mice cannot provide axons with sufficient trophic support, leading to reduced ATP biosynthesis and axonopathy. In conclusion, the MpzT124M mouse model faithfully reproduces the human neuropathy and represents a unique tool for identifying the molecular basis for glial support of axons.


Subject(s)
Charcot-Marie-Tooth Disease , Humans , Mice , Animals , Charcot-Marie-Tooth Disease/genetics , Myelin Sheath/genetics , Myelin Sheath/metabolism , Axons/metabolism , Neuroglia , Mice, Knockout , Disease Models, Animal , Communication
2.
Glia ; 66(4): 789-800, 2018 04.
Article in English | MEDLINE | ID: mdl-29274095

ABSTRACT

Fragile X Syndrome (FXS) is the major cause of inherited mental retardation and the leading genetic cause of Autism spectrum disorders. FXS is caused by mutations in the Fragile X Mental Retardation 1 (Fmr1) gene, which results in transcriptional silencing of Fragile X Mental Retardation Protein (FMRP). To elucidate cellular mechanisms involved in the pathogenesis of FXS, we compared dendritic spines in the hippocampal CA1 region of adult wild-type (WT) and Fmr1 knockout (Fmr1-KO) mice. Using diolistic labeling, confocal microscopy, and three-dimensional electron microscopy, we show a significant increase in the diameter of secondary dendrites, an increase in dendritic spine density, and a decrease in mature dendritic spines in adult Fmr1-KO mice. While WT and Fmr1-KO mice had the same mean density of spines, the variance in spine density was three times greater in Fmr1-KO mice. Reduced astrocyte participation in the tripartite synapse and less mature post-synaptic densities were also found in Fmr1-KO mice. We investigated whether the increase in synaptic spine density was associated with altered synaptic pruning during development. Our data are consistent with reduced microglia-mediated synaptic pruning in the CA1 region of Fmr1-KO hippocampi when compared with WT littermates at postnatal day 21, which is the peak period of synaptic pruning in the mouse hippocampus. Collectively, these results support abnormal synaptogenesis and synaptic remodeling in mice deficient in FMRP. Deficits in the maturation and distribution of synaptic spines on dendrites of CA1 hippocampal neurons may play a role in the intellectual disabilities associated with FXS.


Subject(s)
CA1 Region, Hippocampal/pathology , Fragile X Syndrome/pathology , Synapses/pathology , Animals , Astrocytes/metabolism , Astrocytes/pathology , CA1 Region, Hippocampal/growth & development , CA1 Region, Hippocampal/metabolism , Dendritic Spines/metabolism , Dendritic Spines/pathology , Disease Models, Animal , Fragile X Mental Retardation Protein/genetics , Fragile X Mental Retardation Protein/metabolism , Fragile X Syndrome/metabolism , Imaging, Three-Dimensional , Immunohistochemistry , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Confocal , Microscopy, Electron , Synapses/metabolism
3.
Exp Eye Res ; 166: 131-139, 2018 01.
Article in English | MEDLINE | ID: mdl-29066281

ABSTRACT

To assess serial section block-face scanning electron microscopy (SBFSEM) for retinal pigment epithelium (RPE) ultrastructure, we determined the number and distribution within RPE cell bodies of melanosomes (M), lipofuscin (L), and melanolipofuscin (ML). Eyes of 4 Caucasian donors (16M, 32F, 76F, 84M) with unremarkable maculas were sectioned and imaged using an SEM fitted with an in-chamber automated ultramicrotome. Aligned image stacks were generated by alternately imaging an epoxy resin block face using backscattered electrons, then removing a 125Ā nm-thick layer. Series of 249-499 sections containing 5-24 nuclei were examined per eye. Trained readers manually assigned boundaries of individual cells and x,y,z locations of M, L, and ML. A Density Recovery Profile was computed in three dimensions for M, L, and ML. The number of granules per RPE cell body in 16M, 32F, 76F, and 84M eyes, respectively, was 465Ā Ā±Ā 127 (meanĀ Ā±Ā SD), 305Ā Ā±Ā 92, 79Ā Ā±Ā 40, and 333Ā Ā±Ā 134 for L; 13Ā Ā±Ā 9; 6Ā Ā±Ā 7, 131Ā Ā±Ā 55, and 184Ā Ā±Ā 66 for ML; and 29Ā Ā±Ā 19, 24Ā Ā±Ā 12, 12Ā Ā±Ā 7, and 7Ā Ā±Ā 3 for M. Granule types were spatially organized, with M near apical processes. The effective radius, a sphere of decreased probability for granule occurrence, was 1Ā Āµm for L, ML, and M combined. In conclusion, SBFEM reveals that adult human RPE has hundreds of L, LF, and M and that granule spacing is regulated by granule size alone. When obtained for a larger sample, this information will enable hypothesis testing about organelle turnover and regulation in health, aging, and disease, and elucidate how RPE-specific signals are generated in clinical optical coherence tomography and autofluorescence imaging.


Subject(s)
Lipofuscin/analysis , Melanosomes/ultrastructure , Microscopy, Electron, Scanning/methods , Retinal Pigment Epithelium/ultrastructure , Adult , Aged , Aged, 80 and over , Female , Humans , Male
5.
J Neurosci ; 36(39): 9990-10001, 2016 09 28.
Article in English | MEDLINE | ID: mdl-27683897

ABSTRACT

UNLABELLED: The impact of aging on CNS white matter (WM) is of general interest because the global effects of aging on myelinated nerve fibers are more complex and profound than those in cortical gray matter. It is important to distinguish between axonal changes created by normal aging and those caused by neurodegenerative diseases, including multiple sclerosis, stroke, glaucoma, Alzheimer's disease, and traumatic brain injury. Using three-dimensional electron microscopy, we show that in mouse optic nerve, which is a pure and fully myelinated WM tract, aging axons are larger, have thicker myelin, and are characterized by longer and thicker mitochondria, which are associated with altered levels of mitochondrial shaping proteins. These structural alterations in aging mitochondria correlate with lower ATP levels and increased generation of nitric oxide, protein nitration, and lipid peroxidation. Moreover, mitochondria-smooth endoplasmic reticulum interactions are compromised due to decreased associations and decreased levels of calnexin and calreticulin, suggesting a disruption in Ca(2+) homeostasis and defective unfolded protein responses in aging axons. Despite these age-related modifications, axon function is sustained in aging WM, which suggests that age-dependent changes do not lead to irreversible functional decline under normal conditions, as is observed in neurodegenerative diseases. SIGNIFICANCE STATEMENT: Aging is a common risk factor for a number of neurodegenerative diseases, including stroke. Mitochondrial dysfunction and oxidative damage with age are hypothesized to increase risk for stroke. We compared axon-myelin-node-mitochondrion-smooth endoplasmic reticulum (SER) interactions in white matter obtained at 1 and 12 months. We show that aging axons have enlarged volume, thicker myelin, and elongated and thicker mitochondria. Furthermore, there are reduced SER connections to mitochondria that correlate with lower calnexin and calreticulin levels. Despite a prominent decrease in number, elongated aging mitochondria produce excessive stress markers with reduced ATP production. Because axons maintain function under these conditions, our study suggests that it is important to understand the process of normal brain aging to identify neurodegenerative changes.


Subject(s)
Aging/pathology , Mitochondria/ultrastructure , Optic Nerve/ultrastructure , White Matter/ultrastructure , Aging/physiology , Animals , Male , Mice , Mice, Inbred C57BL , Mitochondria/physiology , Optic Nerve/physiology , Structure-Activity Relationship , White Matter/physiology
6.
Glia ; 65(5): 712-726, 2017 05.
Article in English | MEDLINE | ID: mdl-28191691

ABSTRACT

BACE1 is an indispensable enzyme for generating Ɵ-amyloid peptides, which are excessively accumulated in brains of Alzheimer's patients. However, BACE1 is also required for proper myelination of peripheral nerves, as BACE1-null mice display hypomyelination. To determine the precise effects of BACE1 on myelination, here we have uncovered a role of BACE1 in the control of Schwann cell proliferation during development. We demonstrate that BACE1 regulates the cleavage of Jagged-1 and Delta-1, two membrane-bound ligands of Notch. BACE1 deficiency induces elevated Jag-Notch signaling activity, which in turn facilitates proliferation of Schwann cells. This increase in proliferation leads to shortened internodes and decreased Schmidt-Lanterman incisures. Functionally, evoked compound action potentials in BACE1-null nerves were significantly smaller and slower, with a clear decrease in excitability. BACE1-null nerves failed to effectively use lactate as an alternative energy source under conditions of increased physiological activity. Correlatively, BACE1-null mice showed reduced performance on rotarod tests. Collectively, our data suggest that BACE1 deficiency enhances proliferation of Schwann cell due to the elevated Jag1/Delta1-Notch signaling, but fails to myelinate axons efficiently due to impaired the neuregulin1-ErbB signaling, which has been documented.


Subject(s)
Amyloid Precursor Protein Secretases/metabolism , Aspartic Acid Endopeptidases/metabolism , Cell Proliferation/physiology , Schwann Cells/metabolism , Amyloid Precursor Protein Secretases/genetics , Animals , Aspartic Acid Endopeptidases/genetics , Axons/metabolism , Cell Proliferation/genetics , Mice, Knockout , Myelin Sheath/metabolism , Neurogenesis/genetics , Neurogenesis/physiology , Schwann Cells/cytology , Sciatic Nerve/metabolism , Signal Transduction/physiology
7.
Proc Natl Acad Sci U S A ; 111(27): 9953-8, 2014 Jul 08.
Article in English | MEDLINE | ID: mdl-24958879

ABSTRACT

Axonal degeneration is a primary cause of permanent neurological disability in individuals with the CNS demyelinating disease multiple sclerosis. Dysfunction of axonal mitochondria and imbalanced energy demand and supply are implicated in degeneration of chronically demyelinated axons. The purpose of this study was to define the roles of mitochondrial volume and distribution in axonal degeneration following acute CNS demyelination. We show that the axonal mitochondrial volume increase following acute demyelination of WT CNS axons does not occur in demyelinated axons deficient in syntaphilin, an axonal molecule that immobilizes stationary mitochondria to microtubules. These findings were supported by time-lapse imaging of WT and syntaphilin-deficient axons in vitro. When demyelinated, axons deficient in syntaphilin degenerate at a significantly greater rate than WT axons, and this degeneration can be rescued by reducing axonal electrical activity with the Na(+) channel blocker flecainide. These results support the concept that syntaphilin-mediated immobilization of mitochondria to microtubules is required for the volume increase of axonal mitochondria following acute demyelination and protects against axonal degeneration in the CNS.


Subject(s)
Axons , Mitochondria/metabolism , Multiple Sclerosis/metabolism , Myelin Sheath/metabolism , Nerve Tissue Proteins/physiology , Vesicular Transport Proteins/physiology , Female , Humans , Membrane Proteins , Multiple Sclerosis/genetics , Time-Lapse Imaging
8.
Glia ; 63(1): 66-77, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25066805

ABSTRACT

The central nervous system (CNS) of terrestrial vertebrates underwent a prominent molecular change when proteolipid protein (PLP) replaced P0 protein as the most abundant protein of CNS myelin. However, PLP did not replace P0 in peripheral nervous system (PNS) myelin. To investigate the possible consequences of a PLP to P0 shift in PNS myelin, we engineered mice to express PLP instead of P0 in PNS myelin (PLP-PNS mice). PLP-PNS mice had severe neurological disabilities and died between 3 and 6 months of age. Schwann cells in sciatic nerves from PLP-PNS mice sorted axons into one-to-one relationships but failed to form myelin internodes. Mice with equal amounts of P0 and PLP had normal PNS myelination and lifespans similar to wild-type (WT) mice. When PLP was overexpressed with one copy of the P0 gene, sciatic nerves were hypomyelinated; mice displayed motor deficits, but had normal lifespans. These data support the hypothesis that while PLP can co-exist with P0 in PNS myelin, PLP cannot replace P0 as the major structural protein of PNS myelin.


Subject(s)
Myelin P0 Protein/metabolism , Myelin Proteolipid Protein/metabolism , Myelin Sheath/metabolism , Peripheral Nervous System/metabolism , Schwann Cells/metabolism , Animals , Axons/metabolism , Mice , Myelin P0 Protein/genetics , Myelin-Associated Glycoprotein/metabolism , Sciatic Nerve/metabolism
9.
J Neurosci ; 33(16): 6834-44, 2013 Apr 17.
Article in English | MEDLINE | ID: mdl-23595742

ABSTRACT

The gene encoding the WD repeat-containing protein 81 (WDR81) has recently been described as the disease locus in a consanguineous family that suffers from cerebellar ataxia, mental retardation, and quadrupedal locomotion syndrome (CAMRQ2). Adult mice from the N-ethyl-N-nitrosourea-induced mutant mouse line nur5 display tremor and an abnormal gait, as well as Purkinje cell degeneration and photoreceptor cell loss. We have used polymorphic marker mapping to demonstrate that affected nur5 mice carry a missense mutation, L1349P, in the Wdr81 gene. Moreover, homozygous nur5 mice that carry a wild-type Wdr81 transgene are rescued from the abnormal phenotype, indicating that Wdr81 is the causative gene in nur5. WDR81 is expressed in Purkinje cells and photoreceptor cells, among other CNS neurons, and like the human mutation, the nur5 modification lies in the predicted major facilitator superfamily domain of the WDR81 protein. Electron microscopy analysis revealed that a subset of mitochondria in Purkinje cell dendrites of the mutant animals displayed an aberrant, large spheroid-like structure. Moreover, immunoelectron microscopy and analysis of mitochondrial-enriched cerebellum fractions indicate that WDR81 is localized in mitochondria of Purkinje cell neurons. Because the nur5 mouse mutant demonstrates phenotypic similarities to the human disease, it provides a valuable genetic model for elucidating the pathogenic mechanism of the WDR81 mutation in CAMRQ2.


Subject(s)
Gait Apraxia/genetics , Gait Apraxia/pathology , Nuclear Proteins/metabolism , Photoreceptor Cells/metabolism , Purkinje Cells/metabolism , Actins/metabolism , Alkylating Agents/pharmacology , Analysis of Variance , Animals , Animals, Newborn , Calbindins , Cell Line, Transformed , Cell Survival/drug effects , Cell Survival/genetics , Cerebellum/pathology , Chromosome Mapping , Disease Models, Animal , Ethylnitrosourea/pharmacology , Functional Laterality , Gene Expression Regulation/genetics , Humans , Mice , Mice, Inbred C57BL , Microscopy, Electron, Scanning , Mitochondria/metabolism , Mitochondria/pathology , Mitochondria/ultrastructure , Mutagenesis/drug effects , Mutation, Missense/drug effects , Mutation, Missense/genetics , Nerve Tissue Proteins/metabolism , Nuclear Proteins/genetics , Photoreceptor Cells/drug effects , Photoreceptor Cells/ultrastructure , Prostaglandin-Endoperoxide Synthases/metabolism , Purkinje Cells/drug effects , Purkinje Cells/ultrastructure , RNA, Messenger/metabolism , S100 Calcium Binding Protein G/metabolism , Sequence Analysis, DNA , Transfection
10.
J Neurosci ; 32(34): 11706-15, 2012 Aug 22.
Article in English | MEDLINE | ID: mdl-22915113

ABSTRACT

Intraperitoneal injection of the Gram-negative bacterial endotoxin lipopolysaccharide (LPS) elicits a rapid innate immune response. While this systemic inflammatory response can be destructive, tolerable low doses of LPS render the brain transiently resistant to subsequent injuries. However, the mechanism by which microglia respond to LPS stimulation and participate in subsequent neuroprotection has not been documented. In this study, we first established a novel LPS treatment paradigm where mice were injected intraperitoneally with 1.0 mg/kg LPS for four consecutive days to globally activate CNS microglia. By using a reciprocal bone marrow transplantation procedure between wild-type and Toll-like receptor 4 (TLR4) mutant mice, we demonstrated that the presence of LPS receptor (TLR4) is not required on hematogenous immune cells but is required on cells that are not replaced by bone marrow transplantation, such as vascular endothelia and microglia, to transduce microglial activation and neuroprotection. Furthermore, we showed that activated microglia physically ensheathe cortical projection neurons, which have reduced axosomatic inhibitory synapses from the neuronal perikarya. In line with previous reports that inhibitory synapse reduction protects neurons from degeneration and injury, we show here that neuronal cell death and lesion volumes are significantly reduced in LPS-treated animals following experimental brain injury. Together, our results suggest that activated microglia participate in neuroprotection and that this neuroprotection is likely achieved through reduction of inhibitory axosomatic synapses. The therapeutic significance of these findings rests not only in identifying neuroprotective functions of microglia, but also in establishing the CNS location of TLR4 activation.


Subject(s)
Brain Injuries/drug therapy , Lipopolysaccharides/administration & dosage , Microglia/drug effects , Neuroprotective Agents/administration & dosage , Toll-Like Receptor 4/metabolism , Animals , Antigens, CD/metabolism , Apoptosis/drug effects , Bone Marrow Transplantation , Brain Injuries/pathology , Brain Injuries/surgery , Bromodeoxyuridine/metabolism , Cell Proliferation/drug effects , Central Nervous System/cytology , Central Nervous System/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Administration Schedule , Flow Cytometry , Immunity, Innate/drug effects , In Situ Nick-End Labeling , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Knockout , Microarray Analysis , Microglia/metabolism , Microglia/ultrastructure , Microscopy, Immunoelectron , Motor Cortex/pathology , Motor Cortex/ultrastructure , Synapses/genetics , Synapses/metabolism , Synapses/ultrastructure , Toll-Like Receptor 4/deficiency , Transplantation Chimera
11.
Ann Neurol ; 72(6): 918-26, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23076662

ABSTRACT

OBJECTIVE: Generation and differentiation of new oligodendrocytes in demyelinated white matter is the best described repair process in the adult human brain. However, remyelinating capacity falters with age in patients with multiple sclerosis (MS). Because demyelination of cerebral cortex is extensive in brains from MS patients, we investigated the capacity of cortical lesions to remyelinate and directly compared the extent of remyelination in lesions that involve cerebral cortex and adjacent subcortical white matter. METHODS: Postmortem brain tissue from 22 patients with MS (age 27-77 years) and 6 subjects without brain disease were analyzed. Regions of cerebral cortex with reduced myelin were examined for remyelination, oligodendrocyte progenitor cells, reactive astrocytes, and molecules that inhibit remyelination. RESULTS: New oligodendrocytes that were actively forming myelin sheaths were identified in 30 of 42 remyelinated subpial cortical lesions, including lesions from 3 patients in their 70s. Oligodendrocyte progenitor cells were not decreased in demyelinated or remyelinated cortices when compared to adjacent normal-appearing cortex or controls. In demyelinated lesions involving cortex and adjacent white matter, the cortex showed greater remyelination, more actively remyelinating oligodendrocytes, and fewer reactive astrocytes. Astrocytes in the white matter, but not in cortical portions of these lesions, significantly upregulate CD44, hyaluronan, and versican, molecules that form complexes that inhibit oligodendrocyte maturation and remyelination. INTERPRETATION: Endogenous remyelination of the cerebral cortex occurs in individuals with MS regardless of disease duration or chronological age of the patient. Cortical remyelination should be considered as a primary outcome measure in future clinical trials testing remyelination therapies.


Subject(s)
Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Multiple Sclerosis/pathology , Regeneration/physiology , Adaptor Proteins, Signal Transducing/metabolism , Adult , Adult Stem Cells/metabolism , Adult Stem Cells/pathology , Aged , Antigens/metabolism , Demyelinating Diseases/complications , Demyelinating Diseases/pathology , Female , Glial Fibrillary Acidic Protein/metabolism , Humans , Hyaluronan Receptors/metabolism , Male , Middle Aged , Myelin Proteolipid Protein/metabolism , Myelin Sheath/pathology , Nerve Fibers, Myelinated/pathology , Oligodendroglia/metabolism , Oligodendroglia/pathology , Postmortem Changes , Proteoglycans/metabolism , RNA, Messenger/metabolism
12.
ASN Neuro ; 15: 17590914221146365, 2023.
Article in English | MEDLINE | ID: mdl-36591943

ABSTRACT

The central nervous system (CNS) can be preconditioned to resist damage by peripheral pretreatment with low-dose gram-negative bacterial endotoxin lipopolysaccharide (LPS). Underlying mechanisms associated with transient protection of the cerebral cortex against traumatic brain injury include increased neuronal production of antiapoptotic and neurotrophic molecules, microglial-mediated displacement of inhibitory presynaptic terminals innervating the soma of cortical projection neurons, and synchronized firing of cortical projection neurons. However, the cell types and signaling responsible for these neuronal and microglial changes are unknown. A fundamental question is whether LPS penetrates the CNS or acts on the luminal surface of brain endothelial cells, thereby triggering an indirect parenchymal neuroprotective response. The present study shows that a low-dose intraperitoneal LPS treatment increases brain endothelial cell activation markers CD54, but does not open the blood-brain barrier or alter brain endothelial cell tight junctions as assessed by electron microscopy. NanoString nCounter transcript analyses of CD31-positive brain endothelial cells further revealed significant upregulation of Cxcl10, C3, Ccl2, Il1Ɵ, Cxcl2, and Cxcl1, consistent with identification of myeloid differentiation primary response 88 (MyD88) as a regulator of these transcripts by pathway analysis. Conditional genetic endothelial cell gene ablation approaches demonstrated that both MyD88-dependent Toll-like receptor 4 (TLR4) signaling and Cxcl10 expression are essential for LPS-induced neuroprotection and microglial activation. These results suggest that C-X-C motif chemokine ligand 10 (CXCL10) production by endothelial cells in response to circulating TLR ligands may directly or indirectly signal to CXCR3 on neurons and/or microglia. Targeted activation of brain endothelial receptors may thus provide an attractive approach for inducing transient neuroprotection.


Subject(s)
Lipopolysaccharides , Myeloid Differentiation Factor 88 , Mice , Animals , Lipopolysaccharides/pharmacology , Lipopolysaccharides/metabolism , Myeloid Differentiation Factor 88/genetics , Myeloid Differentiation Factor 88/metabolism , Neuroprotection , Endothelial Cells , Mice, Knockout , Microglia/metabolism , Mice, Inbred C57BL
13.
J Neurosci ; 31(20): 7249-58, 2011 May 18.
Article in English | MEDLINE | ID: mdl-21593309

ABSTRACT

Energy production presents a formidable challenge to axons as their mitochondria are synthesized and degraded in neuronal cell bodies. To meet the energy demands of nerve conduction, small mitochondria are transported to and enriched at mitochondrial stationary sites located throughout the axon. In this study, we investigated whether size and motility of mitochondria in small myelinated CNS axons are differentially regulated at nodes, and whether mitochondrial distribution and motility are modulated by axonal electrical activity. The size/volume of mitochondrial stationary sites was significantly larger in juxtaparanodal/internodal axoplasm than in nodal/paranodal axoplasm. With three-dimensional electron microscopy, we observed that axonal mitochondrial stationary sites were composed of multiple mitochondria of varying length, except at nodes where mitochondria were uniformly short and frequently absent altogether. Mitochondrial transport speed was significantly reduced in nodal axoplasm compared with internodal axoplasm. Increased axonal electrical activity decreased mitochondrial transport and increased the size of mitochondrial stationary sites in nodal/paranodal axoplasm. Decreased axonal electrical activity had the opposite effect. In cerebellar axons of the myelin-deficient rat, which contain voltage-gated Na(+) channel clusters but lack paranodal specializations, axonal mitochondrial motility and stationary site size were similar at Na(+) channel clusters and other axonal regions. These results demonstrate juxtaparanodal/internodal enrichment of stationary mitochondria and neuronal activity-dependent dynamic modulation of mitochondrial distribution and transport in nodal axoplasm. In addition, the modulation of mitochondrial distribution and motility requires oligodendrocyte-axon interactions at paranodal specializations.


Subject(s)
Axons/physiology , Cell Movement/physiology , Mitochondria/physiology , Nerve Fibers, Myelinated/physiology , Ranvier's Nodes/physiology , Animals , Animals, Newborn , Axons/ultrastructure , Central Nervous System/physiology , Central Nervous System/ultrastructure , Cerebellum/physiology , Cerebellum/ultrastructure , Energy Metabolism/physiology , HEK293 Cells , Humans , Male , Mitochondria/ultrastructure , Myelin Sheath/physiology , Myelin Sheath/ultrastructure , Nerve Fibers, Myelinated/ultrastructure , Organ Culture Techniques , Ranvier's Nodes/ultrastructure , Rats , Rats, Sprague-Dawley
14.
Ann Neurol ; 69(3): 445-54, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21446020

ABSTRACT

OBJECTIVE: Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the human central nervous system. Although the clinical impact of gray matter pathology in MS brains is unknown, 30 to 40% of MS patients demonstrate memory impairment. The molecular basis of this memory dysfunction has not yet been investigated in MS patients. METHODS: To investigate possible mechanisms of memory impairment in MS patients, we compared morphological and molecular changes in myelinated and demyelinated hippocampi from postmortem MS brains. RESULTS: Demyelinated hippocampi had minimal neuronal loss but significant decreases in synaptic density. Neuronal proteins essential for axonal transport, synaptic plasticity, glutamate neurotransmission, glutamate homeostasis, and memory/learning were significantly decreased in demyelinated hippocampi, but not in demyelinated motor cortices from MS brains. INTERPRETATION: Collectively, these data support hippocampal demyelination as a cause of synaptic alterations in MS patients and establish that the neuronal genes regulated by myelination reflect specific functions of neuronal subpopulations.


Subject(s)
Axons/pathology , Hippocampus/pathology , Multiple Sclerosis/pathology , Myelin Sheath/pathology , Nerve Fibers, Myelinated/pathology , Synapses/pathology , Axonal Transport/physiology , Axons/physiology , Blotting, Western , Gene Expression , Hippocampus/metabolism , Hippocampus/physiopathology , Humans , Memory/physiology , Multiple Sclerosis/metabolism , Multiple Sclerosis/physiopathology , Myelin Sheath/physiology , Nerve Fibers, Myelinated/physiology , Neurons/pathology , Neurons/physiology , Oligonucleotide Array Sequence Analysis , RNA, Messenger/metabolism , Receptors, Glutamate/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Synapses/physiology , Vesicular Glutamate Transport Proteins/metabolism
15.
J Neurosci ; 30(19): 6658-66, 2010 May 12.
Article in English | MEDLINE | ID: mdl-20463228

ABSTRACT

Axonal degeneration contributes to permanent neurological disability in inherited and acquired diseases of myelin. Mitochondrial dysfunction has been proposed as a major contributor to this axonal degeneration. It remains to be determined, however, if myelination, demyelination, or remyelination alter the size and distribution of axonal mitochondrial stationary sites or the rates of axonal mitochondrial transport. Using live myelinated rat dorsal root ganglion (DRG) cultures, we investigated whether myelination and lysolecithin-induced demyelination affect axonal mitochondria. Myelination increased the size of axonal stationary mitochondrial sites by 2.3-fold. After demyelination, the size of axonal stationary mitochondrial sites was increased by an additional 2.2-fold and the transport velocity of motile mitochondria was increased by 47%. These measures returned to the levels of myelinated axons after remyelination. Demyelination induced activating transcription factor 3 (ATF3) in DRG neurons. Knockdown of neuronal ATF3 by short hairpin RNA abolished the demyelination-induced increase in axonal mitochondrial transport and increased nitrotyrosine immunoreactivity in axonal mitochondria, suggesting that neuronal ATF3 expression and increased mitochondrial transport protect demyelinated axons from oxidative damage. In response to insufficient ATP production, demyelinated axons increase the size of stationary mitochondrial sites and thereby balance ATP production with the increased energy needs of nerve conduction.


Subject(s)
Axonal Transport/physiology , Axons/physiology , Demyelinating Diseases/physiopathology , Ganglia, Spinal/physiopathology , Mitochondria/physiology , Activating Transcription Factor 3/genetics , Activating Transcription Factor 3/metabolism , Animals , Axons/pathology , Demyelinating Diseases/chemically induced , Demyelinating Diseases/pathology , Ganglia, Spinal/pathology , Gene Knockdown Techniques , Immunohistochemistry , In Vitro Techniques , Lysophosphatidylcholines , Microscopy, Electron , Mitochondria/pathology , Myelin Sheath/physiology , Oxidative Stress/physiology , Rats , Rats, Sprague-Dawley , Schwann Cells/physiology , Tyrosine/analogs & derivatives , Tyrosine/metabolism
16.
Acta Neuropathol Commun ; 9(1): 34, 2021 03 01.
Article in English | MEDLINE | ID: mdl-33648591

ABSTRACT

Cognitive dysfunction occurs in greater than 50% of individuals with multiple sclerosis (MS). Hippocampal demyelination is a prominent feature of postmortem MS brains and hippocampal atrophy correlates with cognitive decline in MS patients. Cellular and molecular mechanisms responsible for neuronal dysfunction in demyelinated hippocampi are not fully understood. Here we investigate a mouse model of hippocampal demyelination where twelve weeks of treatment with the oligodendrocyte toxin, cuprizone, demyelinates over 90% of the hippocampus and causes decreased memory/learning. Long-term potentiation (LTP) of hippocampal CA1 pyramidal neurons is considered to be a major cellular readout of learning and memory in the mammalian brain. In acute slices, we establish that hippocampal demyelination abolishes LTP and excitatory post-synaptic potentials of CA1 neurons, while pre-synaptic function of Schaeffer collateral fibers is preserved. Demyelination also reduced Ca2+-mediated firing of hippocampal neurons in vivo. Using three-dimensional electron microscopy, we investigated the number, shape (mushroom, stubby, thin), and post-synaptic densities (PSDs) of dendritic spines that facilitate LTP. Hippocampal demyelination did not alter the number of dendritic spines. Surprisingly, dendritic spines appeared to be more mature in demyelinated hippocampi, with a significant increase in mushroom-shaped spines, more perforated PSDs, and more astrocyte participation in the tripartite synapse. RNA sequencing experiments identified 400 altered transcripts in demyelinated hippocampi. Gene transcripts that regulate myelination, synaptic signaling, astrocyte function, and innate immunity were altered in demyelinated hippocampi. Hippocampal remyelination rescued synaptic transmission, LTP, and the majority of gene transcript changes. We establish that CA1 neurons projecting demyelinated axons silence their dendritic spines and hibernate in a state that may protect the demyelinated axon and facilitates functional recovery following remyelination.


Subject(s)
Cognitive Dysfunction/physiopathology , Demyelinating Diseases/physiopathology , Dendritic Spines/ultrastructure , Hippocampus/pathology , Hippocampus/physiopathology , Multiple Sclerosis/physiopathology , Neurons/metabolism , Neurons/pathology , Animals , Astrocytes/metabolism , Cognitive Dysfunction/etiology , Cuprizone/administration & dosage , Cuprizone/toxicity , Demyelinating Diseases/diagnostic imaging , Demyelinating Diseases/immunology , Demyelinating Diseases/pathology , Disease Models, Animal , Long-Term Potentiation , Magnetic Resonance Imaging , Male , Mice , Mice, Inbred C57BL , Microscopy, Electron , Multiple Sclerosis/diagnostic imaging , Multiple Sclerosis/immunology , Multiple Sclerosis/pathology , Post-Synaptic Density/metabolism , Sequence Analysis, RNA
17.
J Neurosci ; 29(24): 7649-57, 2009 Jun 17.
Article in English | MEDLINE | ID: mdl-19535576

ABSTRACT

We have identified a novel population of cells in the subventricular zone (SVZ) of the mammalian brain that expresses beta4 tubulin (betaT4) and has properties of primitive neuroectodermal cells. betaT4 cells are scattered throughout the SVZ of the lateral ventricles in adult human brain and are significantly increased in the SVZs bordering demyelinated white matter in multiple sclerosis brains. In human fetal brain, betaT4 cell densities peak during the latter stages of gliogenesis, which occurs in the SVZ of the lateral ventricles. betaT4 cells represent <2% of the cells present in neurospheres generated from postnatal rat brain but >95% of cells in neurospheres treated with the anti-mitotic agent Ara C. betaT4 cells produce oligodendrocytes, neurons, and astrocytes in vitro. We compared the myelinating potential of betaT4-positive cells with A2B5-positive oligodendrocyte progenitor cells after transplantation (25,000 cells) into postnatal day 3 (P3) myelin-deficient rat brains. At P20, the progeny of betaT4 cells myelinated up to 4 mm of the external capsule, which significantly exceeded that of transplanted A2B5-positive progenitor cells. Such extensive and rapid mature CNS cell generation by a relatively small number of transplanted cells provides in vivo support for the therapeutic potential of betaT4 cells. We propose that betaT4 cells are an endogenous cell source that can be recruited to promote neural repair in the adult telencephalon.


Subject(s)
Brain/cytology , Oligodendroglia/metabolism , Stem Cells/physiology , Tubulin/metabolism , Animals , Animals, Newborn , Antigens/metabolism , Brain/embryology , Brain/growth & development , Brain/pathology , Cell Proliferation , Cells, Cultured , Female , Gangliosides/metabolism , Humans , Lateral Ventricles/cytology , Lateral Ventricles/pathology , Male , Mice , Middle Aged , Multiple Sclerosis/pathology , Myelin Proteins/deficiency , Myelin Proteolipid Protein/metabolism , Nerve Tissue Proteins/metabolism , Neural Cell Adhesion Molecule L1/metabolism , Neurons/metabolism , Proteoglycans/metabolism , Rats , Rats, Mutant Strains , Sialic Acids/metabolism , Stem Cell Transplantation/mortality
18.
J Comp Neurol ; 528(5): 756-771, 2020 04 01.
Article in English | MEDLINE | ID: mdl-31587284

ABSTRACT

Taste buds comprise four types of taste cells: three mature, elongate types, Types I-III; and basally situated, immature postmitotic type, Type IV cells. We employed serial blockface scanning electron microscopy to delineate the characteristics and interrelationships of the taste cells in the circumvallate papillae of adult mice. Type I cells have an indented, elongate nucleus with invaginations, folded plasma membrane, and multiple apical microvilli in the taste pore. Type I microvilli may be either restricted to the bottom of the pore or extend outward reaching midway up into the taste pore. Type II cells (aka receptor cells) possess a large round or oval nucleus, a single apical microvillus extending through the taste pore, and specialized "atypical" mitochondria at functional points of contact with nerve fibers. Type III cells (aka "synaptic cells") are elongate with an indented nucleus, possess a single, apical microvillus extending through the taste pore, and are characterized by a small accumulation of synaptic vesicles at points of contact with nerve fibers. About one-quarter of Type III cells also exhibit an atypical mitochondrion near the presynaptic vesicle clusters at the synapse. Type IV cells (nonproliferative "basal cells") have a nucleus in the lower quarter of the taste bud and a foot process extending to the basement membrane often contacting nerve processes along the way. In murine circumvallate taste buds, Type I cells represent just over 50% of the population, whereas Types II, III, and IV (basal cells) represent 19, 15, and 14%, respectively.


Subject(s)
Image Processing, Computer-Assisted/methods , Imaging, Three-Dimensional/methods , Microscopy, Electron, Scanning/methods , Taste Buds/ultrastructure , Animals , Mice , Mice, Inbred C57BL
19.
J Neurosci ; 28(28): 7068-73, 2008 Jul 09.
Article in English | MEDLINE | ID: mdl-18614675

ABSTRACT

Axons in the PNS and CNS are ensheathed by multiple layers of tightly compacted myelin membranes. A series of cytoplasmic channels connect outer and inner margins of PNS, but not CNS, myelin internodes. Membranes of these Schmidt-Lantermann (S-L) incisures contain the myelin-associated glycoprotein (MAG) but not P(0) or proteolipid protein (PLP), the structural proteins of compact PNS (P(0)) and CNS (PLP) myelin. We show here that incisures are present in MAG-null and absent from P(0)-null PNS internodes. To test the possibility that P(0) regulates incisure formation, we replaced PLP with P(0) in CNS myelin. S-L incisures formed in P(0)-CNS myelin internodes. Furthermore, axoplasm ensheathed by 65% of the CNS incisures examined by electron microscopy had focal accumulations of organelles, indicating that these CNS incisures disrupt axonal transport. These data support the hypotheses that P(0) protein is required for and can induce S-L incisures and that P(0)-induced CNS incisures can be detrimental to axonal function.


Subject(s)
Axons/metabolism , Myelin P0 Protein/physiology , Myelin Sheath/metabolism , Peripheral Nerves/metabolism , Animals , Axons/ultrastructure , Central Nervous System/metabolism , Central Nervous System/ultrastructure , Gene Expression Regulation/genetics , Mice , Mice, Transgenic , Microscopy, Immunoelectron , Myelin P0 Protein/genetics , Myelin Proteolipid Protein/deficiency , Myelin Sheath/ultrastructure , Myelin-Associated Glycoprotein , Peripheral Nerves/cytology , Receptors, Cell Surface/deficiency
20.
Ann Neurol ; 63(4): 428-35, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18438950

ABSTRACT

OBJECTIVE: Degeneration of chronically demyelinated axons is a major cause of irreversible neurological decline in the human central nervous system disease, multiple sclerosis (MS). Although the molecular mechanisms responsible for this axonal degeneration remain to be elucidated, dysfunction of axonal Na+/K+ ATPase is thought to be central. To date, however, the distribution of Na+/K+ ATPase has not been studied in MS lesions. METHODS: The percentage of axons with detectable Na+/K+ ATPase was determined in 3 acute and 36 chronically demyelinated lesions from 13 MS brains. In addition, we investigated whether postmortem magnetic resonance imaging profiles could predict Na+/K+ ATPase immunostaining in a subset (20) of the chronic lesions. RESULTS: Na+/K+ ATPase subunits alpha1, alpha3, and beta1 were detected in the internodal axolemma of myelinated fibers in both control and MS brains. In acutely demyelinated lesions, Na+/K+ ATPase was detectable on demyelinated axolemma. In contrast, 21 of the 36 chronic lesions (58%) contained less than 50% Na+/K+ ATPase-positive demyelinated axons. In addition, magnetic resonance imaging-pathology correlations of 20 chronic lesions identified a linear decrease in the percentage of Na+/K+ ATPase-positive axons and magnetization transfer ratios (p < 0.0001) and T1 contrast ratios (p < 0.0006). INTERPRETATION: Chronically demyelinated axons that lack Na+/K+ ATPase cannot exchange axoplasmic Na+ for K+ and are incapable of nerve transmission. Loss of axonal Na+/K+ ATPase is likely to be a major contributor to continuous neurological decline in chronic stages of MS, and quantitative magnetization transfer ratios and T1 contrast ratios may provide a noninvasive surrogate marker for monitoring this loss in MS patients.


Subject(s)
Axons/enzymology , Axons/pathology , Magnetic Resonance Imaging/methods , Multiple Sclerosis, Chronic Progressive/enzymology , Multiple Sclerosis, Chronic Progressive/pathology , Sodium-Potassium-Exchanging ATPase/deficiency , Sodium-Potassium-Exchanging ATPase/metabolism , Adult , Aged , Aged, 80 and over , Axons/physiology , Female , Humans , Image Interpretation, Computer-Assisted/methods , Male , Middle Aged , Multiple Sclerosis, Chronic Progressive/etiology , Nerve Fibers, Myelinated/enzymology , Nerve Fibers, Myelinated/pathology , Nerve Fibers, Myelinated/physiology , Protein Subunits/deficiency , Protein Subunits/metabolism , Sodium-Potassium-Exchanging ATPase/physiology
SELECTION OF CITATIONS
SEARCH DETAIL